Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and Safety of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial
Circ Heart Fail 2022 Aug 27;[EPub Ahead of Print], A Peikert, FA Martinez, M Vaduganathan, BL Claggett, IJ Kulac, AS Desai, PS Jhund, RA de Boer, D DeMets, AF Hernandez, SE Inzucchi, MN Kosiborod, CSP Lam, SJ Shah, T Katova, B Merkely, O Vardeny, U Wilderäng, D Lindholm, M Petersson, AM Langkilde, JJV McMurray, SD SolomonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.